Search

Your search keyword '"Gawlik, Radoslaw"' showing total 140 results

Search Constraints

Start Over You searched for: Author "Gawlik, Radoslaw" Remove constraint Author: "Gawlik, Radoslaw"
140 results on '"Gawlik, Radoslaw"'

Search Results

1. Perceptions of the impact of individual allergic rhinitis symptoms: A survey of ARIA clinical experts

2. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

3. Stanowisko Sekcji Anafilaksji, Alergii na Jady Owadów i Mastocytozy Polskiego Towarzystwa Alergologicznego dotyczące zasad diagnostyki nadwrażliwości na jad owadów błonkoskrzydłych.

4. Telemedicine with special focus on allergic diseases and asthma—Status 2022: An EAACI position paper

13. Allergies and COVID-19 vaccines : An ENDA/EAACI Position paper

14. Allergies and COVID-19 vaccines:An ENDA/EAACI Position paper

15. Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper

16. A multi‐disciplinary approach to the diagnosis and management of allergic diseases: An EAACI Task Force

17. ALLERGIC AND HYPERSENSITIVITY CONDITIONS IN NON-SPECIALIST CARE: FLOW-DIAGRAMS TO SUPPORT CLINICAL PRACTICE

19. ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy

20. Management of anaphylaxis due to COVID‐19 vaccines in the elderly

21. Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergy

22. COVID‐19 pandemic and allergen immunotherapy—an EAACI survey

23. COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics - EAACI recommendations

24. Management of anaphylaxis due to COVID-19 vaccines in the elderly

25. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.

26. COVID-19 pandemic:Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

27. Management of anaphylaxis due to COVID-19 vaccines in the elderly

28. COVID-19 pandemic and allergen immunotherapy - an EAACI survey

29. β‐blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy

30. COVID‐19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

31. Isolated allergic conjunctivitis

32. β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy

33. Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergy.

34. A multi‐disciplinary approach to the diagnosis and management of allergic diseases: An EAACI Task Force.

35. Perspectives in allergen immunotherapy: 2019 and beyond

41. Allergen immunotherapy for insect venom allergy: protocol for a systematic review (vol 6, 6, 2016)

42. Allergen immunotherapy for insect venom allergy: protocol for a systematic review

43. Erratum to: Allergen immunotherapy for insect venom allergy: protocol for a systematic review

46. Asthma and exercise-induced respiratory disorders in athletes. The position paper of the Polish Society of Allergology and Polish Society of Sports Medicine.

48. Allergen immunotherapy for insect venom allergy: protocol for a systematic review

50. Standards of nasal provocation tests

Catalog

Books, media, physical & digital resources